Nitric oxide is involved in the response of the isolated intact and epithelium-denuded rat trachea to the β2 adrenergic receptor agonist salbutamol

Respiration

Volumn 80, Issue 5, 2010, Pages 426-432

  Montalvo, F ^a   Cantres Fonseca, O ^a   Santos, G ^a   Vega, M ^a   Torres, I ^a   Carmona, J ^a   Dexter, D ^a   Santacana, G ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Nitric oxide; Rat trachea; Salbutamol

Indexed keywords

CARBACHOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; EPITHELIUM; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA MUSCLE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EPITHELIUM; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; RATS; RATS, SPRAGUE-DAWLEY; TRACHEA;

EID: 77958041848     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319164     Document Type: Article

References (35)

1. Ricciardolo FLM, Sterk PJ, Gaston B, Folk-erts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004: 84: 731-765.
2. Hamad AM, Clayton A, Islam B, Knox AJ: Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol 2003: 285:L973-L983.
3. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugar-baker DJ, Chee C, Singel DJ, Loscalzo J, Stamler JS: Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci 1993; 90:10957-10961.
4. Meurs H, Hamer MAM, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J: Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 2000: 130: 1793-1798.
5. Mayer B, Pfeiffer S, Schrammel A, Koesling D, Schmidt K, Brunner F: A new pathway of nitric oxide/cyclic gmp signaling involving s-nitrosoglutathione. J Biol Chem 1998; 273: 3264-3270.
6. Fang K, Johns R, MacDonald T, Kinter M, Gaston B: S-nitrosoglutathione breakdown pre ve nts a i r way smo ot h mu scle rela x at ion i n t he guinea pig. Am J Physiol 2000; 279:L716-L721.
7. Payne DN, Adock IM, Wilson NM, Oates T, Scallan M, Bush A: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Crit Care Med 2001; 164: 1376-1381.
8. Bommarito L, Migliore E, Bugiani M, Hef-fler E, Guida G, Bucca C, de Marco R, Rolla G: Exhaled nitric oxide in a population sample of adults. Respirat ion 2008; 75: 386-392.
9. Que LG, Yang Z, Stamler JS, Lugogo Njira, Kraft M: S-nitrosoglutathione reductase, an important regulator in human asthma. Am J Respir Crit Ca re Med 2009; 180 : 226-231.
10. Morrison KJ, Gao Y, Vanhoutte PM: Epithelial modulation of airway smooth muscle. Am J Physiol 1990 258:L254-L252.
11. Farmer SG, Fedan JS, Hay DWP, Raeburn D: The effects of epithelium removal on the sensitivity of guinea-pig isolated trachealis to bronchodilator drugs. Br J Pharmac 1986: 89: 407-414.
12. Xiang Y: Endothelium-derived nitric oxide partially mediates salbutamol-induced va-sodilations. Brit J Pharmacol Therapeutics 1993; 250:335-340.
13. Aizawa H, Tanaka H, Sakai J, Takata S, Hara N, Ito Y: L-Name sensitive and insensitive nonadrenergic noncholinergic relaxation of cat airway in vivo and in vitro. Eur Res J 1997; 10: 314-321.
14. Barnes PJ: Nitric oxide and asthmatic inflammation. Immunol 1995; 16:128-130.
15. 2-agonist and anticholinergic drugs in the treatment of lung disease. Proc Am Thorac Soc 2005: 2:305-310.
16. Lefkowitz RJ, Caron M, Michel T, Stadel J: Mechanims of hormone receptor-effector coupling: the B adrenergic receptor and ad-enylate cyclase. Fed Proc 1982; 41: 2664-2670.
17. Rhoden KJ: Inhibition of cholinergic neurotransmission in human airways by -adrenoceptors. J Appl Physiol 1988; 65:700-705.
18. Wessler I, Reinheimer T, Brunn G, Anderson GP, Maclagan J, Racké K: Beta-adrenocep-tors mediate inhibition of [3H]-acetylcholine release from the isolated rat and guinea-pig trachea: role of the airway mucosa and prostaglandins. Br J Pharmacol 1994: 113:1221-1230.
19. Girodet PO, Berger P, Martinez B, Marthan R, Advenier C, Molimard M: Paradoxal effect of salbutamol in an in vitro model of bronchoprotection. Fundam Clin Pharmacol 2005: 19: 179-186.
20. Gonzalez O, Santacana G: Effect of airway epithelium on the contraction of the rat isolated trachea under conditions of low temperature. Respiration 2000; 67:439-442.
21. Flavahan NA, Aarhus LL, Rimele TJ, Van-houtte PM: Respiratory epithelium inhibits bronchial smooth muscle tone. J Appl Physiol 1985; 58: 834-838.
22. Hay DW, Farmer SG, Raeburn D, Robinson VA, Fleming WW, Fedan JS: Airway epithelium modulates the reactivity of guinea-pig respiratory smooth muscle. Eur J Pharmacol 1986; 129:11-18.
23. Barnes PJ, Cuss FM, Palmer JB: The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmacol 1985; 86:685-691.
24. Raeburn D, Hay DW, Farmer SG, Fedan JS: Epithelium removal increases the reactivity of human isolated tracheal muscle to metha-choline and reduces the effect of verapamil. Eur J Pharmacol 1986; 123:451-453.
25. Nijkamp FP, van der Linde HJ, Folkerts G: Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro: role of the epithelium. Am Rev Respir Dis 1993; 148:727-734.
26. Daffonchio L, Hernandez A, Martinotti E, Omici C: B-adrenoceptor reactivity after epithelium removal in guinea pig trachea in vitro. Pharmacol Res 1990; 22:49-58.
27. Chen C-A, Druhan LJ, Varadharaj S, Chen YR, Zweier JL: Phosphorilation of endothe-lial nitric oxide synthase regulates superox-ide generation from the enzyme. J Biol Chem 2008; 283:27038-27047.
28. de Boer J, Meurs H, Flendrig L, Koopal M, Zaagsma J: Role of nitric oxide and superox-ide in allergen-induced airway hyperreactiv-ity after the late asthmatic reaction in guinea pigs. Br J Pharmacol 2001; 133: 1235-1242.
29. Garcia M, Moran A, Luisa Martin M, Bar-thelemebs M, San Roman L: The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. Eur J Pharmacol 2006; 537: 126-134.
30. Wang YX, Poon KS, Randall DJ, Pang: Endo-thelium-derived nitric oxide partially mediates salbutamol-induced vasodilatations. CC Eur J Pharmacol 1993; 250:335-340.
31. Finney MJB: Effects of bronchoconstrictors and bronchodilators on a novel human small air way preparation. Br J Pharmacol 1985; 85; 29-36.
32. Skogvall S, Berglund M, Dalence-Guzman MF, Svensson K, Jonsson P, Persson CG, Sterner O: Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants. Pulm Pharmacol Ther 2007; 20;273-280.
33. Hogg JC: Pathophysiology of airflow limitation in chronic obstructive disease. Lancet 2004; 364:985-996.
34. King GG, Downie SR, Vernbanck S, Thorpe CW, Berend N, Salome CM, Thompson B: Effects of methacholine on small airway function measured by forced oscillation technique and multiple breath nitrogen washout in normal subjects. Respir Physiol Neurobiol 2005; 148 : 165-177.
35. Roche WR: Inflammatory and structural changes in the small airways in bronchial asthma. Am J Respir Crit Care Med 1998; 157:S 191-S194.